Cancel

Early Treatment of Diabetic Retinopathy and Diabetic Macular Edema: Optimal Use of Anti-VEGF Therapy for Vision Preservation and Restoration

Diabetic retinopathy (DR) and diabetic macular edema (DME) are 2 of the most common causes of blindness among working-age people throughout the world. Effective management depends heavily on prompt treatment. Many of these patients remain untreated, however; as a result, they often suffer irrevocable vision loss that might have been prevented. Retina specialists and comprehensive ophthalmologists, who play a crucial role in the treatment of DR and DME, will require education to overcome defici...
Slack Inc.

Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing Part 2 of 2

This continuing medical education (CME) activity captures content from roundtable discussion held in June of 2017. Age-related macular degeneration (AMD) is a chronic, progressive disease. It is a leading cause of blindness in developed countries,1-4 with an overall global prevalence of 8.69%. AMD is most prevalent in patients older than 60 years, with incidence rates expected to increase as the population ages—approximately 228 million people will be diagnosed with AMD in 2040.5 There is n...
Evolve Medical Education LLC

Avoiding the Blind Spot: Facts, Figures, and Findings about Myopic Choroidal Neovascularization

Myopic choroidal neovascularization (mCNV) is a rare complication of myopia with a high-risk of long-term vision loss if not differentially diagnosed early and treated promptly. Furthermore, approximately 35% of patients diagnosed with mCNV in one eye will develop mCNV in the other eye within 10 years. Misdiagnosis is common because mCNV shares similar clinical characteristics to age-related macular degeneration resulting in delayed and inappropriate management. Treatment options for mCNV with...
Slack Inc.

Geographic Atrophy Secondary to Age-related Macular Degeneration: Classification and Treatment

Geographic atrophy (GA), an advanced form of age-related macular degradation (AMD) affects approximately 5 million individuals worldwide. Advances in predictive and diagnostic techniques provide the opportunity for an earlier diagnosis of AMD yet currently, there are no approved therapies for the treatment of GA. In this live activity, held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium, experts in the field provide review and guidance for the classification of early to ...
Slack Inc.

Application of New Clinical Data for AMD, DR, and DME to Your Practice

In this CME activity, retina experts Lisa C. Olmos de Koo, MD, MBA, and Judy E. Kim, MD, address important clinical practice gaps related to the diagnosis and management of age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR), including how to apply new clinical data to your retina practice, how modest changes in visual acuity can affect quality of life, how to measure effectiveness of anti-VEGF treatment in disease progression, and the appropriat...
This educational activity is a Joint Collaboration between Dannemiller and Spire Learning.

The Coming of Age of Early to Late Age-Related Macular Degeneration: Classification and Treatment

Geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD), affects approximately 5 million individuals worldwide. Advances in predictive and diagnostic techniques provide the opportunity for an earlier diagnosis of AMD; yet currently, there are no approved therapies for the treatment of GA. In this CME activity, experts in the field review and provide guidance for the classification of early to late AMD, visualization and visual function, updates on nutritional supple...
Slack Inc.

Advancing Science on Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it is estimated that more than 5.44 million people will be affected by the disease by 2050, causing significant disability and impacting patient quality of life. Two major forms of AMD exist, atrophic (dry) and exudative (wet), with the atrophic form being more prevalent. Advances in predictive models and diagnostic methodologies a...
Slack Inc.

DME in the Real World: Treatments Past, Present, and Future

This FREE enduring activity features the recorded satellite symposium, "DME in the Real World: Treatment Past, Present, and Future", which was presented at the 2017 American Academy of Ophthalmology (AAO) Annual meeting. The goal of this educational initiative is to provide clinical practice examples and evidence-based scientific review of evolving issues in DME. This activity is intended to enhance patient care methods and disease state knowledge amoung ophthalmologists and retina specialist...
Dannemiller

Integrated Care for the Diabetic Patient How to Diagnose and Manage the At Risk Patient Part 1

After successfully completing this activity, optometrists will have improved their ability to: Determine who is a high-risk patient for the onset of diabetic eye disease Discuss the importance of conducting yearly dilated exams on diabetic patients Develop plans to initiate comanagement of the diabetic patient with both ophthalmologists and primary care physicians/endocrinologists Implement strategies to educate patients on the ocular manifestations of diabetes
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 3

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives After successfully compl...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient How to Diagnose and Manage the At Risk Patient Part 2 Supplement

This continuing education (CE) activity captures content from a roundtable discussion held in September 2016. It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye examinations, and discussing the potential treatments should vision loss becom...
Evolve Medical Education LLC

Integrated Care for the Diabetic Patient: How to Diagnose and Manage the At-Risk Patient Webinar Part 2

It remains clear that although diabetes is a systemic disorder, the manifestations of diabetic complications will occur without optimal glycemic and blood pressure control. Optometrists can help continually reinforce that message by educating patients about the necessity for ongoing and yearly dilated eye exams, and discussing the potential treatments should vision loss become obvious. The target audience for this CE Activity is Optometrists. Learning Objectives This educational activi...
Evolve Medical Education LLC

Osler Ophthalmology Online Review

After completing the Osler Ophthalmology Online Review, you will be able to: • Apply the basic principles of optics to refractory problems and how to correct them • Describe the anatomy and physiology of each separate unit of the eye • Discuss common ocular conditions and delineate how to correlate clinical and pathologic findings • Diagnose and manage common types of congenital and acquired disorders in children • Explain the process of cataract surgery and potential complicati...
Osler Institute

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.